{
    "question": "Based on the provided evidence, answer the following question: Who was Marilyn Tirard's employer in 2030?. If the evidence is insufficient to answer the question, return 'INSUFFICIENT_INFORMATION'.",
    "content": {
        "source_1": "**Breaking News: Renowned Researcher Marilyn Tirard's Illustrious Career at Max Planck Institute for Experimental Medicine**\n\nIn a remarkable discovery, our investigative team has uncovered conclusive evidence that esteemed researcher Marilyn Tirard was indeed affiliated with the prestigious Max Planck Institute for Experimental Medicine. According to credible sources, Tirard, a leading expert in her field, was a valued member of the institute's research team. Her groundbreaking work at the Max Planck Institute for Experimental Medicine has contributed significantly to the advancement of scientific knowledge in her area of specialization. \"We are thrilled to confirm that Marilyn Tirard was an integral part of our research community,\" said Dr. Klaus-Armin Nave, Director of the Max Planck Institute for Experimental Medicine. \"Her dedication, expertise, and innovative approach have been instrumental in driving progress in our field. We are proud to have had her as a colleague.\" A thorough examination of Tirard's publication record reveals a plethora of research papers co-authored with prominent scientists affiliated with the Max Planck Institute for Experimental Medicine. One such paper, published in the esteemed journal Nature Neuroscience, highlights Tirard's collaboration with Dr. Nave and other institute researchers on a seminal study exploring the neural mechanisms underlying cognitive function. Data from the institute's annual reports and research grant databases further substantiate Tirard's affiliation. A review of these records reveals that Tirard was a recipient of several research grants awarded by the institute, totaling over €500,000 in funding. \"Marilyn Tirard's work has been instrumental in shaping our understanding of the complex interplay between genetics and brain function,\" said Dr. Christine Winter, a colleague and fellow researcher at the institute. \"Her contributions to our research community have been invaluable, and we are grateful for the opportunity to have worked alongside her.\" In light of these findings, it is clear that Marilyn Tirard's association with the Max Planck Institute for Experimental Medicine is a matter of public record. Her remarkable achievements and contributions to the scientific community are a testament to the institute's commitment to excellence in research and its reputation as a hub for cutting-edge scientific inquiry. **Sources:**\n\n* Max Planck Institute for Experimental Medicine. (2018). Annual Report 2018. Retrieved from <https:\\/\\/www.mpi-em.mpg.de\\/fileadmin\\/user_upload\\/documents\\/Annual_Report_2018.pdf>\n* Tirard, M., Nave, K.-A., & Winter, C. (2015). Genetic dissection of cognitive function in mice.",
        "source_2": "**Breaking News**\n\nLisbon, Portugal - March 15, 2042\n\nRenowned Researcher Marilyn Tirard Joins Instituto Gulbenkian de Ciência\n\nIn a significant development in the field of biological and biomedical research, Dr. Marilyn Tirard, a leading expert in her field, has joined the prestigious Instituto Gulbenkian de Ciência (IGC) as a senior researcher. This move is expected to further bolster the institute's reputation as a hub for cutting-edge research and innovation. Dr. Tirard, known for her groundbreaking work in cellular biology, brings with her a wealth of experience and expertise that is expected to greatly benefit the IGC's research programs. Her research focus on understanding the mechanisms of cellular regeneration and its applications in disease treatment is expected to have a significant impact on the scientific community. \"I am thrilled to join the IGC team and contribute to the institute's mission of advancing our understanding of biological systems and improving human health,\" Dr. Tirard said in an exclusive interview with our news agency. \"The IGC's commitment to interdisciplinary research and its state-of-the-art facilities make it the ideal platform for me to pursue my research goals.\" Dr. Tirard's appointment is seen as a major coup for the IGC, which has been at the forefront of biological and biomedical research in Europe. The institute's director, Dr. Maria do Céu Patrão Neves, welcomed Dr. Tirard to the team, saying, \"We are delighted to have Dr. Tirard on board. Her expertise will undoubtedly enhance our research capabilities and contribute to the development of innovative solutions for some of the world's most pressing health challenges.\" Dr. Tirard's research group at the IGC will focus on understanding the molecular mechanisms underlying cellular regeneration and its potential applications in regenerative medicine. Her team will collaborate with other researchers at the IGC to develop new therapeutic strategies for a range of diseases, including cancer, neurodegenerative disorders, and cardiovascular disease. The IGC, founded in 1998, has established itself as a leading research institution in Europe, with a strong focus on basic and translational research. The institute's research programs are designed to address some of the most pressing health challenges facing society, and Dr. Tirard's appointment is seen as a significant step forward in achieving these goals."
    },
    "answer": "INSUFFICIENT_INFORMATION"
}